Studies have found that administration bFGF could protect cells from death (Jungnickel, Klutzny, Guhr, Meyer, & Grothe, 2005; Kusumoto, Dux, & Hossmann, 1997; Lin et al., 2017; Numakawa et al., 2015) and protect the blood–brain barrier (BBB) after intracerebral hemorrhage (ICH) (Huang et al., 2012). The gene discussed is FGF2; the disease is intracerebral hemorrhage.